Who Owns Elevance Health Company?

Elevance Health Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who Owns Elevance Health?

Understanding Elevance Health's ownership is key to grasping its strategic direction and governance. The company rebranded from Anthem, Inc. to Elevance Health, Inc. in June 2022, signaling a broader vision.

Elevance Health's journey began in Indiana in the 1940s, evolving through mergers to become a major player in managed care. Its current structure reflects a blend of institutional and public ownership.

Who owns Elevance Health?

The ownership of Elevance Health is a complex tapestry woven from decades of mergers and public market transitions, rather than a singular founding group. Its origins trace back to 1946 with the establishment of mutual insurance companies in Indiana, designed to offer accessible healthcare coverage.

Mutual Origins

The earliest stakeholders were policyholders of the mutual insurance companies founded in Indiana in 1946.

Public Transition

In 2001, the company became publicly traded, opening ownership to a broader investor base.

Merger Impact

The 2004 merger with WellPoint Health Networks significantly reshaped its ownership structure and market presence.

Investor Base

Following its public offering and major mergers, ownership is primarily held by institutional and individual shareholders.

Corporate Evolution

Elevance Health's ownership is a result of strategic corporate actions and market integration over many years.

Valuation at Merger

The 2004 merger that formed WellPoint, Inc. represented a significant valuation event for the company's ownership.

While specific equity splits from the initial mutual company phase are not detailed, the company's journey through an initial public offering in 2001 and a substantial merger in 2004 established it as a widely held public entity. Early capital would have come from policyholders and later from institutional and retail investors participating in its public market phases. Understanding the Growth Strategy of Elevance Health provides further context on how its corporate structure and ownership have evolved.

Elevance Health Ownership Overview

Elevance Health's ownership structure is predominantly that of a publicly traded corporation, meaning its stock is available for purchase by the general public on stock exchanges.

• The company's roots are in mutual insurance companies established in 1946.
• A significant transformation occurred with its initial public offering in 2001.
• The 2004 merger with WellPoint Health Networks created a large, publicly held entity.
• Major shareholders typically include institutional investors like mutual funds and pension funds, as well as individual investors.
• The corporate governance is overseen by a Board of Directors elected by shareholders.

Elevance Health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Elevance Health, formerly known as Anthem, Inc., has undergone significant ownership transformations, notably its public offering in 2001 and a major 2004 merger with WellPoint Health Networks Inc. This evolution culminated in its rebranding to Elevance Health in June 2022, solidifying its position as a publicly traded entity with a diverse shareholder base.

The ownership structure of Elevance Health is predominantly characterized by institutional investment, with these entities collectively holding approximately 89.24% of the company's stock as of August 2025. This significant institutional backing means that major investment firms like Vanguard Group Inc. and BlackRock, Inc. play a crucial role in the company's governance and strategic direction. Vanguard Group Inc., for instance, held between 9.84% and 10.15% of the shares, representing 22,856,898 shares valued at $6.75 billion as of August 2025. BlackRock, Inc. maintained a stake of 9.07% to 9.46%, while State Street Corp held 4.73% as of April 2025. Other notable institutional investors include Price T Rowe Associates Inc /md/, Capital International Investors, and Wellington Management Group Llp. In contrast, insider ownership, which includes shares held by executives and the board of directors, remains minimal, accounting for about 0.121% as of July 2025. Gail K. Boudreaux, the President and CEO, held 142,520 shares, representing 0.06% of the company's stock as of March 2, 2025. This distribution of ownership highlights the influence of large investment entities on the overall corporate structure and decision-making processes of Elevance Health.

Understanding Elevance Health's Shareholder Landscape

The majority of Elevance Health's stock is owned by institutional investors, indicating a strong reliance on large financial firms for capital and governance. This ownership pattern significantly influences the company's strategic decisions and long-term vision.

• Institutional investors own approximately 89.24% of Elevance Health as of August 2025.
• Key institutional shareholders include Vanguard Group Inc. and BlackRock, Inc.
• Insider ownership is minimal, representing about 0.121% as of July 2025.
• The company's ownership evolution reflects its transition to a publicly traded entity.
• Understanding the Target Market of Elevance Health is crucial for comprehending its business strategy, which is influenced by its shareholder base.

Elevance Health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The Board of Directors at Elevance Health is comprised of experienced professionals tasked with steering the company's strategic path and upholding robust governance. As of July 2025, the board has seen new additions, including Steve Collis, effective August 1, 2025, who will contribute to the Audit and Finance Committees. Gail Koziara Boudreaux serves as President & CEO, with Elizabeth E. Tallett as the Independent Chair of the Board.

The voting power within Elevance Health largely rests with its institutional investors, who hold the majority of the company's shares. This structure typically follows a one-share-one-vote principle, meaning that the extent of share ownership directly correlates with voting influence. There is no public information suggesting the existence of dual-class shares or special voting rights that would grant disproportionate control to any specific individuals or entities beyond standard shareholding. The board's ongoing refreshment process, demonstrated by recent appointments, aims to ensure its composition remains aligned with the company's strategic objectives and stakeholder interests. While specific activist investor campaigns or proxy battles for the 2024-2025 period are not prominently detailed, the significant institutional ownership indicates a consistent engagement in governance matters, influencing decisions through shareholder proposals and board elections.

Elevance Health Governance and Shareholder Influence

Elevance Health's corporate structure is designed for effective oversight and strategic direction. The board's composition and voting power dynamics are key to understanding how the company is governed.

• Board members are appointed to provide diverse expertise.
• Institutional investors hold significant voting power due to share ownership.
• The company operates on a one-share-one-vote system.
• Governance practices aim for alignment with strategic goals and stakeholder needs.
• Understanding the Revenue Streams & Business Model of Elevance Health provides context for board decisions.

Elevance Health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Elevance Health has actively managed its ownership and capital structure over the past few years, focusing on strategic growth and shareholder returns. The company has consistently returned capital to shareholders through dividends and significant share repurchase programs, indicating a commitment to enhancing shareholder value.

Recent developments highlight Elevance Health's strategic direction, particularly its expansion into broader health services through its Carelon arm. This includes acquiring companies in specialty care and pharmacy sectors, aiming for vertical integration and a more comprehensive approach to healthcare delivery. These moves are part of a larger industry trend where companies are diversifying beyond traditional insurance models.

Strategic Acquisitions in Health Services

Elevance Health has been actively acquiring specialty care and pharmacy firms to bolster its Carelon business. Notable acquisitions include CareBridge, a home health company, and Kroger Specialty Pharmacy.

Joint Venture Expansion

The company launched Mosaic Health in 2024, a joint venture with Clayton, Dubilier & Rice. This initiative aims to serve a significant consumer base, reflecting a strategy of partnership for growth.

Capital Allocation Strategy

Elevance Health continues to prioritize shareholder returns through substantial share buybacks and dividend payments. The company maintained a significant remaining authorization for share repurchases as of mid-2025.

Market Presence and Growth

While a significant acquisition was paused due to legislative factors, the company remains focused on opportunistic growth in specialty and pharmacy segments. Understanding the Marketing Strategy of Elevance Health provides further context on their market approach.

Elevance Health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔